NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/01/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization9 mln
Float35.80 mln
Earnings Date08/06/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-1.31
Manipulation likely
Relative Strength
0
/ 100
Severely lagging
Debt / Equity
0.03
Debt-free
ROE
-124
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Vistagen Therapeutics is a South San Francisco-based company founded in 1998 that focuses on developing new medicines for mental health and brain-related conditions. Its most advanced treatments are delivered through nasal sprays and work by targeting natural signaling pathways in the body, with several candidates currently in mid- to late-stage clinical trials addressing conditions such as social anxiety, depression, menopausal symptoms, and appetite loss. The company also has a partnership with AffaMed Therapeutics to bring one of its key treatments to patients across multiple markets.
